| GOLDMAN SACHS EMERGING MARKETS EQUITY ESG PORTFOLIO P USD CAP | RVI EMERGENTES | 38,01% | 79,98% | 33,31% | · |
| AB SICAV I-EUROZONE GROWTH PORTFOLIO S1X EUR | RV EURO | 9,33% | 33,82% | 33,30% | 106,71% |
| CAPITAL GROUP EUROPEAN CORE EQUITY FUND (LUX) ZLD EUR | RVI EUROPA VALOR | 12,72% | 33,40% | 33,30% | · |
| DWS INVEST II ESG US TOP DIVIDEND LCH (P) | RVI USA VALOR | 9,42% | 36,97% | 33,30% | 69,72% |
| FRANKLIN MENA A (YDIS) USD | RVI EMERGENTES | 5,26% | 9,69% | 33,30% | 100,64% |
| BROWN ADVISORY US SMALL CAP BLEND C USD ACC | RVI USA SMALL/MID CAP | 19,58% | 33,50% | 33,29% | 135,81% |
| CAPITAL GROUP EUROPEAN CORE EQUITY FUND (LUX) ZD EUR | RVI EUROPA VALOR | 12,72% | 33,39% | 33,29% | 64,29% |
| FRANKLIN GLOBAL CONVERTIBLE SECURITIES I (ACC) USD | RFI GLOBAL CONVERTIBLES | 17,21% | 43,87% | 33,29% | 164,32% |
| GOLDMAN SACHS GLOBAL MULTI-ASSET GROWTH PORTFOLIO R PH GBP DIS | MIXTO AGRESIVO GLOBAL | 12,82% | 44,75% | 33,29% | 91,65% |
| BGF WORLD HEALTHSCIENCE I2 EUR | RVI BIOTECNOLOGÍA | 23,38% | 22,75% | 33,28% | · |
